Changes in state-specific childhood obesity and overweight prevalence in the United States from 2003 to 2007

Gopal K Singh1, Michael D Kogan, Peter C van Dyck

  • 1US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau, 5600 Fishers Ln, Rockville, MD 20857, USA. gsingh@hrsa.gov

Insights

Childhood obesity and overweight prevalence increased nationwide between 2003 and 2007, with significant state-level variations. Addressing geographic disparities offers potential for substantial reductions in pediatric obesity rates.

Area of Science:

  • Pediatric Public Health
  • Epidemiology
  • Childhood Obesity Research

Background:

  • Childhood obesity is a significant public health concern in the United States.
  • Prevalence rates have shown concerning trends in recent decades.
  • Understanding geographic variations is crucial for targeted interventions.

Purpose of the Study:

  • To analyze state-specific changes in childhood obesity and overweight prevalence from 2003 to 2007.
  • To identify geographic disparities in pediatric weight status across the US.
  • To explore factors contributing to these observed variations.

Main Methods:

  • Temporal cross-sectional analysis using National Survey of Children's Health data (2003 and 2007).
  • Inclusion of 46,707 children (2003) and 44,101 children (2007) aged 10-17 years.
  • Bivariate and logistic regression analyses to examine prevalence and odds of obesity and overweight.

Main Results:

  • In 2007, 16.4% of US children were obese and 31.6% were overweight.
  • Significant state-level disparities were observed, with Mississippi highest and Oregon lowest for obesity.
  • Obesity prevalence increased by 10% overall (18% in females) between 2003-2007, with notable state-specific increases and decreases.

Conclusions:

  • Substantial geographic disparities in childhood obesity and overweight prevalence persist in the US.
  • An upward trend in prevalence was noted in several states between 2003 and 2007.
  • Targeting these geographic disparities presents a significant opportunity to reduce overall childhood obesity rates.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...